FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/069637 [Registered on: 27/06/2024] Trial Registered Prospectively
Last Modified On: 26/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Other 
Public Title of Study   To find out if having trouble putting in breathing tubes is related to having trouble putting in feeding tubes during gallbladder surgery under general anaesthesia. 
Scientific Title of Study   To find any correlation between difficult intubation and difficult orogastric tube insertion in patients undergoing laparoscopic cholecystectomy under general anaesthesia A prospective observational study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vivek Sharma 
Designation  Junior Resident 
Affiliation  Dr Rajendra Prasad Government Medical College kangra at Tanda 
Address  Department of Anaesthesia Dr Rajendra Prasad Government Medical College Kangra at TANDA HIMACHAL PRADESH

Kangra
HIMACHAL PRADESH
176001
India 
Phone  7018200891  
Fax    
Email  sharma.vivek108@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shyam Bhandari 
Designation  Associate Professor 
Affiliation  Dr Rajendra Prasad Government Medical College kangra at Tanda 
Address  Department Of Anaesthesia Dr Rajendra Prasad Government Medical College Kangra at TANDA HIMACHAL PRADESH

Kangra
HIMACHAL PRADESH
176001
India 
Phone  7018200891  
Fax    
Email  dr.bhandari@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Vivek Sharma 
Designation  Junior Resident 
Affiliation  Dr RPGMC Kangra at TANDA 
Address  Department of Anaesthesia Dr RPGMC Kangra at TANDA HIMACHAL PRADESH

Kangra
HIMACHAL PRADESH
176001
India 
Phone  7018200891  
Fax    
Email  sharma.vivek108@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Dr Rajendra Prasad Government medical college Kangra at TANDA 
Address  Department of Anaesthesiology Dr Rajendra Prasad Government Medical College Kangra at Tanda  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vivek sharma  Dr Rajendra Prasad Government Medical College Kangra at Tanda  Department of Anaesthesia Operation Theatre complex third floor
Kangra
HIMACHAL PRADESH 
7018200891

sharma.vivek108@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Dr Rajendra Prasad Government Medical College Kangra at Tanda  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K802||Calculus of gallbladder without cholecystitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  ASA class 1-2
BMI 18.5-29.9
Undergoing elective laparoscopic cholecystectomy under general anaesthesia requiring orogastric tube insertion 
 
ExclusionCriteria 
Details  Patient refusal.
Patient with ASA 3-4.
deformity of chin, pharynx or larynx.
Patient planned for fibreoptic intubation in view of anticipated difficult intubation. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
It is an observational study to find any relation between difficult intubation and difficult orogastric tube insertion in patient undergoing laparoscopic cholecystectomy under general anaesthesia.  18 months 
 
Secondary Outcome  
Outcome  TimePoints 
To find any correlation between difficult intubation by IDS & difficult orogastric tube insertion.   18 months 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   16/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers who provide a methodologically sound proposal.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Data are available indefinitely at (Link to be included sharma.vivek108@gmail.com).

  6. For how long will this data be available start date provided 01-01-2025 and end date provided 01-01-2030?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   Patients enrolled in the study will have the anesthetic procedure explained and give written consent. Before surgery, a case record form will be completed for each patient. Patients will fast for at least 8 hours prior and receive premedication with Alprazolam 0.25mg and Ranitidine 150 mg at 6:00 am on the surgery day. Upon arrival in the operating theatre, standard monitoring and an intravenous line will be set up. Baseline parameters will be recorded.

Premedication with Midazolam 0.03 mg/kg and Fentanyl  2ug/kg will be administered, followed by pre-oxygenation. Induction will involve Propofol 1.5 -2mg/kg and atracurium 0.5mg/kg as a muscle relaxant. The laryngoscope will be used for direct laryngoscopy and endotracheal intubation will be performed, documenting Cormack -lehane grading and Intubation difficulty score.

After intubation, a refrigerated orogastric tube will be inserted through the oral route. Multiple attempts will be made using different techniques if initial insertion fails. Final confirmation of tube placement will be done via auscultation. Success rates and any adverse effects will be documented, and the orogastric tube will be inspected for blood post-surgery.
 
Close